Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Return on Capital %

Acadia Pharmaceutica Return on Capital % Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Return on Capital % from 2010 to 2020.
  • Acadia Pharmaceutica Return on Capital % for the quarter ending June 06, 2020 was -16.69 a -23.77% increase of 3.97 year over year
  • Acadia Pharmaceutica Return on Capital % for the last 12 months ending June 06, 2020 was -27.46 a -26.97% increase of 7.40 year over year
  • Acadia Pharmaceutica Annual Return on Capital % for 2019 was -25.94 a -46.41% increase of 12.04 from 2018
  • Acadia Pharmaceutica Annual Return on Capital % for 2018 was -37.98 a -12.73% increase of 4.83 from 2017
  • Acadia Pharmaceutica Annual Return on Capital % for 2017 was -42.82 a -10.91% increase of 4.67 from 2016
Other Margins & Efficiency Metrics:
  • Acadia Pharmaceutica EBITDA Margin for the quarter ending December 12, 2018 was $-112m a 0.94% decrease of -1m year over year
  • Acadia Pharmaceutica Return on Equity % for the quarter ending September 09, 2018 was -101.83 a 24.07% decrease of -24.52 year over year
View Chart On Koyfin

Quarterly ACAD Return on Capital % Data

06/2020-16.69
03/2020-33.00
12/2019-20.02
09/2019-20.65
06/2019-34.41
03/2019-48.22
12/2018-47.88
09/2018-62.76
06/2018-56.32
03/2018-42.86

Annual ACAD Return on Capital % Data

2019-25.94
2018-37.98
2017-42.82
2016-47.48
2015-38.05
2014-23.70
2013-17.92
2012-24.09
2011-53.73
201044.56